Orange Book product · Generic (ANDA)
METHOCARBAMOL
METHOCARBAMOL
At a glance
Oct 26, 2018
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 26, 2018
7 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
METHOCARBAMOL
Strength
1GM/10ML (100MG/ML)
Dosage form
SOLUTION
Route
IM-IV
TE code
AP
Application
ANDA 211504
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHOCARBAMOL
- 2025ATMEKSIBrand (NDA)
NDA 219843 · ROSEMONT PHARMS
- —ROBAXINBrand (NDA)
NDA 011790 · HIKMA
- 2023METHOCARBAMOLGeneric (ANDA)
ANDA 212707 · MIKART
- 2023METHOCARBAMOLGeneric (ANDA)
ANDA 213967 · AUROBINDO PHARMA LTD
- 2022METHOCARBAMOLGeneric (ANDA)
ANDA 215065 · BAXTER HLTHCARE CORP
- 2021METHOCARBAMOLGeneric (ANDA)
ANDA 200958 · BOSTAL
- 2018METHOCARBAMOLGeneric (ANDA)
ANDA 209312 · GRANULES
- 2018METHOCARBAMOLGeneric (ANDA)
ANDA 209331 · FRESENIUS KABI USA
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 206071 · NAVINTA LLC
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 207522 · SOMERSET THERAPS LLC
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 205404 · SAGENT PHARMS INC
- 2017METHOCARBAMOLGeneric (ANDA)
ANDA 207496 · AM REGENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
